TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/13/2026
Back to search
Official data from USPTO
EXCEEDING YOUR EXPECTATIONS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
EXCEEDING YOUR EXPECTATIONS
ST13
US500000077364597Class
35, 39, 41, 42, 45
Filing
77364597
Registration
3702365
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
08/14/2026
Trademark type
Word
Nice classes
35, 39, 41, 42, 45
Filing date
01/04/2008
Registration date
10/27/2009
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/11/2019
Last transaction
08/14/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
02/28/2007
First use in commerce
02/28/2007
Drawing code
4
Owner type
11
Owner location
OTTAWA, ON, CA
Examiner
CAPSHAW, DANIEL
Law office
M10
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
ALLPHASE CLINICAL RESEARCH SERVICES INC.
Allphase Clinical Research (US), Inc.
Representatives
Mary Margaret L. O'Donnell Blue Filament Law PLLC
Technical classification
Nice Classes
Class 35Class 39Class 41Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Pre-clinical to phase four clinical trial management servicespre-study document collection and reviewsite selectionvisits and auditssite complianceproject tracking and monitoring reportsnegotiation and administration of investigator grantslabelingpackagingdistributioncoordination and tracking of clinical trial products and materialsregulatory document processingcentral laboratory selection and coordination; pre-clinical to phase four clinical trial management servicesmanaging site and study-specific subject recruitment strategies and programs in the nature of contingency strategies and solutions to address specific project challenges; pre-clinical to phase four clinical trial management servicesmanaging the development of all study related documents and materials in the nature of study protocolsamendmentspaper and electronic case report formsinformed consent formsdiary cardssafety narrativespresentation posterstechnical briefs and training manuals; pre-clinical to phase four clinical trial management servicesmanaging all aspects of studydrug reconciliationinventory and distribution reportsmanaging all aspects of clinical trialsmanaging investigatorstechniciansparticipantsethical reviewsinvestigator meetingsdatabasesstatistical analyses and reportingrandomization logisticsmedical writing servicesrecruitment of investigatorstechnicians and participants; providing data management services in the medicalpharmaceutical and biotechnological field
Class 39
Clinical supply storage in the field of clinical and medical supplies
Class 41
Providing training in the field of clinical trials and clinical trial management for the pharmaceutical and biotechnological industries
Class 42
Medical and scientific research consulting regarding pre-clinical to phase four clinical trials; providing quality assurance services in the pharmaceutical and biotechnological industries
Class 45
Regulatory affairsreviewing standards and practices to assure compliance with clinical trial laws and regulations
Publications
History of USPTO decisions and trademark events.
41 publications found
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
08/13/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/13/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/13/2026
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/29/2020
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
12/11/2019
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
12/11/2019
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
12/11/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/11/2019
E89R
TEAS SECTION 8 & 9 RECEIVED
10/28/2019
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
10/27/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/25/2017
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
10/01/2015
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/01/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/01/2015
E815
TEAS SECTION 8 & 15 RECEIVED
08/27/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
10/27/2009
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
09/24/2009
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/24/2009
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/11/2009
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/08/2009
IUAF
USE AMENDMENT FILED
08/11/2009
EISU
TEAS STATEMENT OF USE RECEIVED
08/11/2009
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
02/17/2009
PUBO
PUBLISHED FOR OPPOSITION
11/25/2008
NPUB
NOTICE OF PUBLICATION
11/05/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/17/2008
ALIE
ASSIGNED TO LIE
10/17/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/03/2008
XAEC
EXAMINER'S AMENDMENT ENTERED
10/03/2008
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/03/2008
GNEA
EXAMINERS AMENDMENT E-MAILED
10/03/2008
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/03/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/02/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/02/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/02/2008
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/04/2008
GNRT
NON-FINAL ACTION E-MAILED
04/04/2008
CNRT
NON-FINAL ACTION WRITTEN
04/04/2008
DOCK
ASSIGNED TO EXAMINER
04/03/2008
NWAP
NEW APPLICATION ENTERED
01/08/2008
Continuous trademark protection
Get notified about every new filing that threatens EXCEEDING YOUR EXPECTATIONS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.